They report a similar downregulation of PER1, PER2, CRY2, and HLF, in breast cancer samples while CLOCK, ARNTL(BMAL1), and BHLHE40 levels remained relatively unchanged (66). This evidence concerns the gene CRY2 and breast carcinoma.